Biblio

Export 167 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
H. Kikuchi, Takahashi, M., Komatsu, H., and Axelsen, P. H., “Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal.”, J Alzheimers Dis, vol. 92, no. 2, pp. 499-511, 2023.
S. J. Kiddle, Voyle, N., and Dobson, R. J. B., “A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.”, J Alzheimers Dis, vol. 64, no. s1, pp. S289-S297, 2018.
J. Kida, Nemoto, K., Ikejima, C., Bun, S., Kakuma, T., Mizukami, K., and Asada, T., “Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 405-15, 2016.
M. Khosravi, Peter, J., Wintering, N. A., Serruya, M., Shamchi, S. Pourhassan, Werner, T. J., Alavi, A., and Newberg, A. B., “18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.”, J Alzheimers Dis, vol. 70, no. 4, pp. 1197-1207, 2019.
P. Emami Khoonsari, Shevchenko, G., Herman, S., Remnestål, J., Giedraitis, V., Brundin, R. M., Gunnarsson, M. Degerman, Kilander, L., Zetterberg, H., Nilsson, P., Lannfelt, L., Ingelsson, M., and Kultima, K., “Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 67, no. 2, pp. 639-651, 2019.
M. Khondoker, Rafnsson, S. Bjorn, Morris, S., Orrell, M., and Steptoe, A., “Positive and Negative Experiences of Social Support and Risk of Dementia in Later Life: An Investigation Using the English Longitudinal Study of Ageing.”, J Alzheimers Dis, vol. 58, no. 1, pp. 99-108, 2017.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B., “Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
S. A. Khmeleva, Radko, S. P., Kozin, S. A., Kiseleva, Y. Y., Mezentsev, Y. V., Mitkevich, V. A., Kurbatov, L. K., Ivanov, A. S., and Makarov, A. A., “Zinc-Mediated Binding of Nucleic Acids to Amyloid-β Aggregates: Role of Histidine Residues.”, J Alzheimers Dis, vol. 54, no. 2, pp. 809-19, 2016.
M. Rafi Khezri, Ghasemnejad-Berenji, M., and Moloodsouri, D., “The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?”, J Alzheimers Dis, vol. 92, no. 2, pp. 391-393, 2023.
E. M. Khedr, Omeran, N., Ramadan, H. Karam- Alla, Ahmed, G. K., and Abdelwarith, A. M., “Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
W. Khan, Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Lemaître, H., Nees, F., Paus, T., Pausova, Z., Rietschel, M., Smolka, M. N., Ströhle, A., Gallinat, J., Vellas, B., Soininen, H., Kloszewska, I., Tsolaki, M., Mecocci, P., Spenger, C., Villemagne, V. L., Masters, C. L., Muehlboeck, J. - S., Bäckman, L., Fratiglioni, L., Kalpouzos, G., Wahlund, L. - O., Schumann, G., Lovestone, S., Williams, S. C. R., Westman, E., and Simmons, A., “A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
D. Singh Khalsa and Newberg, A. B., “Spiritual Fitness: A New Dimension in Alzheimer's Disease Prevention.”, J Alzheimers Dis, vol. 80, no. 2, pp. 505-519, 2021.
N. Ketter, H Brashear, R., Bogert, J., Di, J., Miaux, Y., Gass, A., Purcell, D. D., Barkhof, F., and H Arrighi, M., “Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 57, no. 2, pp. 557-573, 2017.
M. Kero, Raunio, A., Polvikoski, T., Tienari, P. J., Paetau, A., and Myllykangas, L., “Hippocampal Sclerosis in the Oldest Old: A Finnish Population-Based Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 263-272, 2018.
O. Keret, Shochat, T., Steiner, I., and Glik, A., “Non-Ashkenazi Jewish Origin is Associated with Early Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 877-884, 2018.
K. P. Kepp, Sensi, S. L., Johnsen, K. B., Barrio, J. R., Høilund-Carlsen, P. F., Neve, R. L., Alavi, A., Herrup, K., Perry, G., Robakis, N. K., Vissel, B., and Espay, A. J., “The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.”, J Alzheimers Dis, vol. 94, no. 2, pp. 497-507, 2023.
K. Planeta Kepp, “Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 447-457, 2017.
B. A. Kent, Strittmatter, S. M., and Nygaard, H. B., “Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1325-1336, 2018.
G. Kennedy, Hardman, R. J., Macpherson, H., Scholey, A. B., and Pipingas, A., “How Does Exercise Reduce the Rate of Age-Associated Cognitive Decline? A Review of Potential Mechanisms.”, J Alzheimers Dis, vol. 55, no. 1, pp. 1-18, 2017.
G. Kennedy, Meyer, D., Hardman, R. J., Macpherson, H., Scholey, A. B., and Pipingas, A., “Physical Fitness and Aortic Stiffness Explain the Reduced Cognitive Performance Associated with Increasing Age in Older People.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1307-1316, 2018.
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., “Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.
D. Kempuraj, Selvakumar, G. Pushpavath, Thangavel, R., Ahmed, M. Ejaz, Zaheer, S., Kumar, K. Kuppamma, Yelam, A., Kaur, H., Dubova, I., Raikwar, S. P., Iyer, S. S., and Zaheer, A., “Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1117-1129, 2018.
N. Kemppainen, Joutsa, J., Johansson, J., Scheinin, N. M., Någren, K., Rokka, J., Parkkola, R., and Rinne, J. O., “Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 48, no. 1, pp. 123-33, 2015.
D. Kelly, Coen, R. F., Akuffo, K. Owusu, Beatty, S., Dennison, J., Moran, R., Stack, J., Howard, A. N., Mulcahy, R., and Nolan, J. M., “Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids.”, J Alzheimers Dis, vol. 48, no. 1, pp. 261-77, 2015.
A. Keleman, Wisch, J. K., Bollinger, R. M., Grant, E. A., Benzinger, T. L., Morris, J. C., Ances, B. M., and Stark, S. L., “Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 2, pp. 843-853, 2020.

Pages